VerifyRecall
Alerts
ACTIVE RECALL — CLASS IIActive recallD-0418-2025/FDA enforcement
L'oreal USA·Cosmetics·Mar 5, 2025

La Roche-posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne…

What you need to know

Class II

  • What happened

    CGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the…

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. A known human carcinogen that can be introduced through contaminated ingredients or manufacturing processes.

  • Action required

    Stop applying or using the product. Check the UPC and lot codes below, then return it to the retailer or contact the manufacturer about a refund or replacement.

Active recall · classified by the FDANationwide (US)More cosmetics

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Share via WhatsApp

Match before you discard

Product identification

Source: FDA COSMETICS

Brand nameL'oreal USA
Recalling firmL'oreal USAClark, NJ, United States
UPC / barcodes
8 83140 03527 58 83140 03528 2
Lot / date codes
  • Lot #s, Expiration Dates: MYX30W, Exp 03/31/2025 MYX32W, Exp 03/31/2025 MYX33W, Exp 03/31/2025 MYX41W, Exp 04/30/2025 MYX42W, Exp 04/30/2025 MYX43W, Exp 04/30/2025 MYX44W, Exp 04/30/2025 MYX45W, Exp 04/30/2025 MYX50W, Exp 05/31/2025 MYX51W, Exp 04/30/2025 MYX52W, Exp 04/30/2025 MYX53W, Exp 05/31/2025 MYX70W, Exp 07/31/2025 MYX80W, Exp 07/31/2025 MYX81W, Exp 07/31/2025 MYX90W, Exp 08/31/2025 MYX91W, Exp 08/31/2025 MYX92W, Exp 08/31/2025 MYX93W, Exp 08/31/2025 MYXD0W, Exp 09/30/2025 MYXO1W, Exp 09/30/2025 MYXO2W, Exp 09/30/2025 MYXO3W, Exp 09/30/2025 MYXO4W, Exp 09/30/2025 MYXO5W, Exp 09/30/2025 MYY21W, Exp 02/28/2026 MYY23W, Exp 02/28/2026 MYY26W, Exp 02/28/2026 MYY27W, Exp 02/28/2026 MYY31W, Exp 03/31/2026 MYY32W, Exp 11/30/2025 MYY33W, Exp 11/30/2025 MYY34W, Exp 03/31/2026 MYY50W, Exp 05/31/2026 MYY51W, Exp 05/31/2026 MYY60W, Exp 05/31/2026 MYY61W, Exp 03/31/2026 MYY62W, Exp 06/30/2026 MYY63W, Exp 06/30/2026 MYY64W, Exp 06/30/2026 MYY72W, Exp 06/30/2026 MYY73W, Exp 06/30/2026 MYY74W, Exp 06/30/2026 MYY75W, Exp 06/30/2026 MYY76W, Exp 06/30/2026.
Distribution area
Nationwide

Nationwide in the USA

United States

Quantity affected14, 460 bottles
Recall initiationFDA report date: May 21, 2025
FDA recall numberD-0418-2025

Beyond the headline

The recall, in context

L'oreal USA initiated this cosmetics recall on March 5, 2025. The FDA enforcement report states: CGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots. The FDA report lists distribution as: Nationwide in the USA.

The FDA enforcement report describes the reason as: CGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.

La Roche-posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne… was made or distributed by L'oreal USA in Clark, NJ, United States. This page reflects FDA report D-0418-2025, dated May 21, 2025.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, a known human carcinogen that can be introduced through contaminated ingredients or manufacturing processes.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Set the product aside and do not apply it.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Benzene contamination

Possible health effects

Benzene is a known human carcinogen. Long-term exposure is associated with blood disorders and cancer. A recall is a precautionary step to reduce exposure.

When symptoms may appear

Health effects are generally associated with repeated or long-term exposure rather than a single incubation period.

Higher-risk groups

People who use the affected product frequently, pregnant people, children and people with existing blood disorders should be especially cautious.

What to do now

  1. 1Stop using the affected cosmetic or personal-care product immediately.
  2. 2Keep the package and contact the retailer or manufacturer about a refund or replacement; do not use it as a substitute.
  3. 3If you have concerns about exposure or symptoms, speak with a healthcare professional.

Benzene is a known human carcinogen; this information is not a personal exposure assessment.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the La Roche-posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne… recall?

L'oreal USA recalled La Roche-posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne… in an FDA Class II enforcement action reported as D-0418-2025. CGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the…

What should I do if I bought this product?

Stop applying or using the product. Check the UPC and lot codes below, then return it to the retailer or contact the manufacturer about a refund or replacement. Stop using the affected cosmetic or personal-care product immediately. Keep the package and contact the retailer or manufacturer about a refund or replacement; do not use it as a substitute. If you have concerns about exposure or symptoms, speak with a healthcare professional.

Is the L'oreal USA recall still active?

Yes. As of the latest FDA enforcement report, this recall is listed as ongoing. Check the official source record for the most current status before making a decision.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record D-0418-2025. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by L'oreal USA

View brand
Class II·

L'oreal USA

La Roche-posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl…

CGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the…

Nationwide (US)Cosmetics
Class II·

L'oreal USA

La Roche-posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl…

Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

Nationwide (US)Cosmetics

Related alerts

Recent Benzene recalls

All alerts
Class II·

Owen Biosciences INC.

Fhf Farmhouse Fresh, Midnight Clearing, Night Lotion, 2.5% Benzoyl Peroxide Acne Treatment, Otc…

Chemical contamination: Presence of benzene

Nationwide (US)Cosmetics
Class II·

Owen Biosciences INC.

Hydropeptide Clear Alliance Serum, 2.5% Benzoyl Peroxide, A)1 FL Oz/30ml

Chemical contamination: Presence of benzene

Nationwide (US)Cosmetics

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.